OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
OncoC4 has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in October 2025.
OncoC4's investors include 3E Bioventures, Kaitai Capital, HM Capital, GBA Fund.
OncoC4 is headquartered in Rockville, United States.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.
OncoC4 is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OncoC4 — Funding & Investors." VCBacked, October 2, 2025, https://www.vcbacked.co/company/oncoc4. Accessed August 14, 2026.
VCBacked. (2025). OncoC4 — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/oncoc4
{{cite web |title=OncoC4 — Funding & Investors |url=https://www.vcbacked.co/company/oncoc4 |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated